Page last updated: 2024-08-25

rosiglitazone and Nasopharyngeal Carcinoma

rosiglitazone has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Hahn, SS; Tang, Q; Wu, J; Zhao, S; Zheng, F	1

Other Studies

1 other study(ies) available for rosiglitazone and Nasopharyngeal Carcinoma

Article	Year
Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1. Cellular signalling, 2014, Volume: 26, Issue:3 Topics: AMP-Activated Protein Kinases; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Metformin; Mutation; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; PPAR gamma; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Sp1 Transcription Factor; Thiazolidinediones; Transcription Factor AP-2	2014

Article

Year

Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.

Cellular signalling, 2014, Volume: 26, Issue:3

Topics: AMP-Activated Protein Kinases; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Metformin; Mutation; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; PPAR gamma; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Sp1 Transcription Factor; Thiazolidinediones; Transcription Factor AP-2

2014